688176 亞虹醫藥
按盤價 
11.650 +1.720 (+17.321%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -4.328 | -17.628 | -15.524 | -8.525 | -12.303 |
| 總資產報酬率 ROA (%) | -3.810 | -15.821 | -14.545 | -8.256 | -11.919 |
| 投入資產回報率 ROIC (%) | -4.012 | -16.609 | -15.076 | -8.472 | -12.247 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.871 | 75.540 | 78.998 | 73.022 | 84.989 |
| 營業利潤率 (%) | -140.291 | -190.415 | -2,937.490 | -948,649.406 | -5,210,058.993 |
| 息稅前利潤/營業總收入 (%) | -138.013 | -199.958 | -3,197.334 | -1,037,721.275 | -5,122,199.049 |
| 淨利潤/營業總收入 (%) | -141.309 | -191.504 | -2,914.455 | -944,804.606 | -5,135,637.810 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.240 | 105.337 | 107.943 | 125.221 | 108.671 |
| 價值變動淨收益/利潤總額(%) | -7.511 | -6.322 | -6.324 | -23.476 | -6.975 |
| 營業外收支淨額/利潤總額(%) | 0.778 | 0.773 | -0.623 | -0.932 | -1.533 | 償債能力分析 |
| 流動比率 (X) | 8.048 | 7.769 | 12.816 | 34.217 | 40.716 |
| 速動比率 (X) | 8.015 | 7.739 | 12.808 | 34.182 | 40.665 |
| 資產負債率 (%) | 12.598 | 11.364 | 9.213 | 3.583 | 2.774 |
| 帶息債務/全部投入資本 (%) | 5.793 | 3.676 | 3.065 | -0.130 | 0.176 |
| 股東權益/帶息債務 (%) | 1,583.361 | 2,548.554 | 3,089.060 | -76,383.985 | 56,417.493 |
| 股東權益/負債合計 (%) | 694.362 | 779.598 | 984.723 | 2,690.805 | 3,504.356 |
| 利息保障倍數 (X) | -40.858 | 24.812 | 11.500 | 10.607 | -558.185 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 94.414 | 61.240 | 113.751 | 141.021 | 342.000 |
| 存貨周轉天數 (天) | 45.296 | 27.202 | 274.394 | 168,675.349 | 2,100,090.830 |
| 備註： | 即時報價更新時間為 14/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
